The new frontier of genome engineering with CRISPR-Cas9
Jennifer A. Doudna, Emmanuelle Charpentier
Howard Hughes Medical Institute Lawrence Berkeley National Laboratory University of California, Berkeley Medizinische Hochschule Hannover
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
The advent of facile genome engineering using the bacterial RNA-guided CRISPR-Cas9 system in animals and plants is transforming biology. We review the history of CRISPR (clustered regularly interspaced palindromic repeat) biology from its initial discovery through the elucidation of the CRISPR-Cas9 enzyme mechanism, which has set the stage for remarkable developments using this technology to modify, regulate, or mark genomic loci in a wide variety of cells and organisms from all three domains of life. These results highlight a new era in which genomic manipulation is no longer a bottleneck to experiments, paving the way toward fundamental discoveries in biology, with applications in all branches of biotechnology, as well as strategies for human therapeutics.
逐年被引趋势
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
可就本文提问;依据不足时会说明。
学术脉络
学科主题
生物医学CRISPR and Genetic Engineering
RNA regulation and disease · Bacterial Genetics and Biotechnology
参考文献 154
此处列出前 3 条
引用本文 7,042
按被引量排序,此处列出前 3 条